Madrigal Pharmaceuticals (MDGL) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-4.98
-4.7
-4.43
-4.15

Details

Expected EPS
-4.58
Actual EPS
-4.69
Surprise EPS
-0.11
Surprise Percent
+2.4%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -4.69 per share for Q2 2023.

0 Comments

Share your thoughts